AP-32 (N = 89) | CP-9 (N = 96) | Placebo (N = 92) | P-value | |
---|---|---|---|---|
Gender (M/F) | 46/43 | 41/55 | 51/41 | 0.198 |
BBW (g) | 3069.96 ± 36.10 | 3087.29 ± 33.94 | 3097.54 ± 35.71 | 0.858 |
Delivery method (NSD/C/S) | 65/24 | 76/20 | 77/15 | 0.214 |
Gestational age (weeks) | 37.93 ± 0.12 | 37.99 ± 0.12 | 38.08 ± 0.12 | 0.702 |
Baseline serum bilirubin (mg/dL) | 15.84 ± 0.25 | 16.08 ± 0.23 | 15.67 ± 0.23 | 0.466 |
Endpoint serum bilirubin (mg/dL) | 11.00 ± 0.15 | 11.21 ± 0.14 | 10.99 ± 0.14 | 0.464 |
Duration of hospital stay (hours) | 57.06 ± 2.05* | 62.34 ± 2.12 | 64.30 ± 2.51 | 0.066 |
Δ Jaundice index (mg/dL) | −4.84 ± 0.27 | −4.88 ± 0.25 | −4.68 ± 0.27 | 0.859 |